Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
Authors
Keywords
-
Journal
SEMINARS IN CANCER BIOLOGY
Volume 93, Issue -, Pages 20-35
Publisher
Elsevier BV
Online
2023-05-05
DOI
10.1016/j.semcancer.2023.04.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma
- (2023) Lilong Zhang et al. Journal of Translational Medicine
- Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
- (2022) Nicolas Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
- (2022) Pierluigi Ramadori et al. HEPATOLOGY
- Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis
- (2022) Heejoon Jang et al. HEPATOLOGY
- Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis
- (2022) Daryl Ramai et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
- (2022) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
- (2022) Qian Song et al. Biomedicines
- Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study
- (2022) Daniel Q. Huang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease
- (2022) Stergios A. Polyzos et al. Hormones-International Journal of Endocrinology and Metabolism
- Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
- (2022) Imaad Said et al. World Journal of Gastrointestinal Oncology
- Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
- (2022) Stergios A. Polyzos et al. Current Obesity Reports
- Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
- (2022) Linda Henry et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
- (2022) Utibe-Abasi S. Udoh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)
- (2022) Wenyu Luo et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)
- (2022) R.S. Finn et al. ANNALS OF ONCOLOGY
- LBA35 Camrelizumab (C) plus rivoceranib (R) vs. sorafenib (S) as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A randomized, phase III trial
- (2022) S. Qin et al. ANNALS OF ONCOLOGY
- LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
- (2022) S. Qin et al. ANNALS OF ONCOLOGY
- NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
- (2022) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma
- (2022) Arndt Vogel et al. LANCET
- How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
- (2022) Konstantinos Arvanitakis et al. Cancers
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- (2022) Clinical and Molecular Hepatology
- Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
- (2021) Jason Behary et al. Nature Communications
- The Association between Diet and Hepatocellular Carcinoma: A Systematic Review
- (2021) Elena S. George et al. Nutrients
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- LI-RADS v2018 major criteria: do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?
- (2021) Maxime Barat et al. EUROPEAN JOURNAL OF RADIOLOGY
- Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
- (2021) Pankaj Gupta et al. JOURNAL OF HEPATOLOGY
- Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
- (2021) Alberto Zanetto et al. Cancers
- Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians
- (2021) Daniel Geh et al. Hepatobiliary Surgery and Nutrition
- Efficacy of Dietary Manipulations for Depleting Intrahepatic Triglyceride Content: Implications for the Management of Non-alcoholic Fatty Liver Disease
- (2021) Karoline Sandby et al. Current Obesity Reports
- Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT
- (2021) Jeong Ah Hwang et al. EUROPEAN RADIOLOGY
- Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity
- (2021) Vinod K. Rustgi et al. GASTROENTEROLOGY
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)
- (2021) Patrizia Burra et al. LIVER INTERNATIONAL
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
- (2021) Masatoshi Kudo et al. Liver Cancer
- Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
- (2021) Stergios A. Polyzos et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis
- (2021) Kanokwan Pinyopornpanish et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
- (2021) Haley Schoenberger et al. Clinical Gastroenterology and Hepatology
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
- (2021) Judith Dalem et al. HEPATOLOGY
- Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
- (2021) Victoria Potoupni et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Rational screening approaches for HCC in NAFLD patients
- (2021) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Inadequate Ultrasound Examination in Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis
- (2021) Seung Baek Hong et al. Journal of Clinical Medicine
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
- (2021) Giulio Marchesini et al. DIGESTIVE AND LIVER DISEASE
- Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
- (2021) Jennifer R. Kramer et al. HEPATOLOGY
- Nonalcoholic fatty liver disease: lifestyle and quality of life
- (2021) Ilias Vachliotis et al. Hormones-International Journal of Endocrinology and Metabolism
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The fecal mycobiome in non-alcoholic fatty liver disease
- (2021) Münevver Demir et al. JOURNAL OF HEPATOLOGY
- HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
- (2021) Georg Semmler et al. JOURNAL OF HEPATOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
- (2021) Ziniu Ding et al. Frontiers in Immunology
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis
- (2020) Adrian T. Billeter et al. JOURNAL OF GASTROINTESTINAL SURGERY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
- (2020) Sunyoung Lee et al. LIVER INTERNATIONAL
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysis
- (2020) Rupie Jamwal et al. Abdominal Radiology
- Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
- (2020) Won Jin Ho et al. Journal for ImmunoTherapy of Cancer
- Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
- (2020) Motoyasu Kojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
- (2020) Sunyoung Lee et al. Journal of the American College of Radiology
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Mechanisms of nonalcoholic fatty liver disease and implications for surgery
- (2020) Benedikt Kaufmann et al. LANGENBECKS ARCHIVES OF SURGERY
- Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
- (2020) Evangelia Makri et al. ARCHIVES OF MEDICAL RESEARCH
- Hepatokines and adipokines in NASH-related hepatocellular carcinoma
- (2020) Ozlem Kucukoglu et al. JOURNAL OF HEPATOLOGY
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC
- (2019) Tian Yang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
- (2019) Kazuhisa Kodama et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma
- (2019) Paulo Henrique Lima et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
- (2019) Myriam Alexander et al. BMC Medicine
- Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block
- (2019) Vasilios G. Athyros et al. Current Vascular Pharmacology
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- National Experience on Down‐staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP , and Wait Time
- (2019) Neil Mehta et al. HEPATOLOGY
- NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
- (2019) Clemens Schotten et al. Liver Cancer
- The Immunobiology of Hepatocellular Carcinoma in Humans and Mice: Basic Concepts and Therapeutic Implications
- (2019) Jiajie Hou et al. JOURNAL OF HEPATOLOGY
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
- (2019) Victor Cunha et al. Annals of Hepatology
- MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH)
- (2019) Fatima Al-Sharhan et al. EUROPEAN JOURNAL OF RADIOLOGY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
- (2018) Jessica L. Petrick et al. BRITISH JOURNAL OF CANCER
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
- (2018) Takefumi Kimura et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI
- (2018) Scott M Thompson et al. BRITISH JOURNAL OF RADIOLOGY
- LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
- (2018) Seung Soo Kim et al. EUROPEAN RADIOLOGY
- Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients
- (2018) Takanori Ito et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis
- (2018) George N. Ioannou et al. PLoS One
- Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
- (2018) Marcus Grohmann et al. CELL
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Association of Physical Activity and Risk of Hepatobiliary Cancers: A Multinational Cohort Study
- (2018) Sebastian E. Baumeister et al. JOURNAL OF HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obesity and cancer risk: Emerging biological mechanisms and perspectives
- (2018) Konstantinos I. Avgerinos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
- (2018) Tracey G. Simon et al. JAMA Oncology
- Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
- (2018) Hayato Nakagawa et al. Cancers
- Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
- (2017) Andrea Casadei Gardini et al. EUROPEAN JOURNAL OF CANCER
- Coffee consumption and risk of nonalcoholic fatty liver disease
- (2017) Karn Wijarnpreecha et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
- (2017) Lewis R. Roberts et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
- (2017) Teng-Yu Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis
- (2017) M Zhou et al. ONCOGENE
- Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
- (2017) Loreto Boix et al. SEMINARS IN LIVER DISEASE
- MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis
- (2017) Aline de Conti et al. Oncotarget
- Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
- (2017) Oliver John Kennedy et al. BMJ Open
- Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ
- (2017) An Tang et al. Abdominal Radiology
- MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
- (2017) So Yeon Kim et al. JAMA Oncology
- Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer
- (2016) M. Walker et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
- (2016) O. Simmons et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
- (2016) Andrea Marengo et al. Annual Review of Medicine
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
- (2016) Helen L. Reeves et al. DIGESTIVE DISEASES AND SCIENCES
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression
- (2016) Yuya Seko et al. HEPATOLOGY RESEARCH
- Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
- (2016) Antonio Facciorusso et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Nonalcoholic fatty future disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver
- (2016) M. Lafitte et al. Diagnostic and Interventional Imaging
- Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
- (2015) Arndt Weinmann et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
- (2015) Bashar Mohamad et al. Hepatology International
- HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance
- (2015) Marcin Krawczyk et al. JOURNAL OF HEPATOLOGY
- The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
- (2015) Cristina Margini et al. LIVER INTERNATIONAL
- Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
- (2015) Hamza Chettouh et al. LIVER INTERNATIONAL
- Silencing ofmicroRNA-122is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis
- (2014) Yoko Takaki et al. CANCER SCIENCE
- Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings
- (2014) Michele Di Martino et al. EUROPEAN RADIOLOGY
- miRNA in hepatocellular carcinoma
- (2014) Asahiro Morishita et al. HEPATOLOGY RESEARCH
- HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
- (2014) Samuele De Minicis et al. PLoS One
- CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features
- (2014) Jin-Young Choi et al. RADIOLOGY
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Obesity, adipokines and hepatocellular carcinoma
- (2013) Xiao-Feng Duan et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- Obesity, insulin resistance, NASH and hepatocellular carcinoma
- (2013) Jun Yu et al. SEMINARS IN CANCER BIOLOGY
- Liver Transplantation for Nonalcoholic Steatohepatitis
- (2012) Vatche G. Agopian et al. ANNALS OF SURGERY
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
- (2012) Lisa B. VanWagner et al. HEPATOLOGY
- Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
- (2012) Vikrant V. Sahasrabuddhe et al. JNCI-Journal of the National Cancer Institute
- Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008
- (2012) Ju Dong Yang et al. MAYO CLINIC PROCEEDINGS
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
- (2011) Yusuke Kawamura et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
- (2011) Ping Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
- (2011) Katsutoshi Tokushige et al. JOURNAL OF GASTROENTEROLOGY
- Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?
- (2011) Florian Hucke et al. WIENER KLINISCHE WOCHENSCHRIFT
- Population-based risk factors and resource utilization for HCC: US perspective
- (2010) A. Sanyal et al. CURRENT MEDICAL RESEARCH AND OPINION
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease
- (2010) Stergios A. Polyzos et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Liver Transplantation in Patients With Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
- (2009) Shahid M. Malik et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
- (2009) Stergios Polyzos et al. CURRENT MOLECULAR MEDICINE
- The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease
- (2009) Stergios A. Polyzos et al. DIABETES OBESITY & METABOLISM
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
- (2009) Natsuko Kawada et al. JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now